Healthcare, Nutrition, and Medical Devices by Abbott

0.2927
0.0051
1.77 %
Daily range
Weekly range
  • Mykhailo Ihnatenko
  • 14.10.2026
Abbott stock tests pivotal support at $101.82 with mixed technical signals: weekly analysis
Shares of Abbott Laboratories (ABT) are trading near $102 after gaining about 2.6% this week. The chart reflects a rally that has run into overbought conditions, with ...
  • Ashutosh Sureka
  • 12.10.2026
What's behind Abbott's latest stock surge?
Abbott Laboratories (ABT) climbed 2.4% following the release of strong second-quarter results and new product launches, fueling renewed buying interest. The rally looks limited as ABT remains ...
  • Viktoras Karapetjanc
  • 05.10.2026
FDA approval for CardioMEMS HF System update lifts Abbott stock after upbeat trading
Abbott (ABT) stock is trading at $100.44 after climbing 3% on the day. The price sits above its key short- and medium-term moving averages but remains below its ...
  • Andrey Mastykin
  • 30.09.2026
Abbott Laboratories stock drops about 1.5% after negative momentum signals and moving average breaks
Abbott Laboratories (ABT) slumped 1.48% as persistent selling pressure dominated the session, even as its recently declared dividend and continued product rollout offered a positive backdrop. The ...
  • Viktoras Karapetjanc
  • 28.09.2026
Abbott shares weekly forecast: Rebound odds stay low with RSI nearing oversold territory
Shares of Abbott Laboratories (ABT) are trading near $101 as sellers keep pressure on the stock, with a setup that has now pushed deep into oversold territory. After a ...
  • Yaroslav Dmytrenko
  • 24.09.2026
Abbott Laboratories shares drop almost 2% after ongoing operational challenges and partnership announcement
Abbott Laboratories (ABT) extended its decline by 1.82% after ongoing competitive pressure and a sluggish recovery in its nutrition business were reported, with segment challenges and a recent ...
  • Jainam Mehta
  • 17.09.2026
What's behind Abbott's latest 1.6% stock pullback?
Abbott Laboratories (ABT) fell 1.57% as technical selling pressure accelerated, with bearish momentum and negative signals from multiple indicators driving price action. The intensity of the move ...
  • Dmytro Kharkov
  • 15.09.2026
Abbott stock weekly forecast: Downside risk emerges as volatility stays elevated and recovery remains unconfirmed
Shares of Abbott Laboratories (ABT) are trading near $102 as sellers keep pressure on the stock with the setup deep in oversold territory. Despite the technical tension, ...
  • Ashutosh Sureka
  • 08.09.2026
Why is Abbott Laboratories stock down 1.8% today?
Abbott Laboratories (ABT) fell 1.87% as heavy intraday selling outweighed continued signs of institutional investment interest and stable earnings. The decline is further supported by the stock ...
  • Sergey Shendetskyi
  • 03.09.2026
Why is Abbott stock down 1.9% today?
Abbott Laboratories (ABT) slid 1.9% as near-term seller pressure weighed on the stock, even as the absence of new company-specific developments kept the news flow muted. The move faces limits, ...
  • Aleksandra Chaikina
  • 03.09.2026
Abbott shares slide nearly 3% amid mixed momentum signals and volatility spike: weekly analysis
Shares of Abbott Laboratories (ABT) are trading near $109, sliding almost 3% over the past week as sellers remain in control with the setup pushed deep into oversold ...
  • Ciaran Ryan
  • 02.09.2026
Why is Abbott Laboratories stock up 2% today?
Abbott Laboratories (ABT) climbed 2.06% after strong institutional inflows and robust quarterly earnings. The advance looks limited, with the stock still trading below its 20-day moving average ...
  • Ciaran Ryan
  • 31.08.2026
What's behind Abbott Laboratories's latest stock pullback?
Abbott Laboratories (ABT) fell 1.73% after renewed selling pressure, even as recent institutional investment and a positive earnings report provided a constructive backdrop. The move faces limits, ...
  • Ashutosh Sureka
  • 25.08.2026
Abbott Laboratories receives U.S. FDA authorization for Libre Duo system as stock edges lower
Abbott Laboratories has received U.S. FDA authorization for its Libre Duo 10 Day system, a first-of-its-kind, two-in-one biowearable designed for people living with diabetes. The stock edges lower ...
  • Ashutosh Sureka
  • 25.08.2026
Abbott stock weekly forecast: Recent rally bracketed by support at $112.91 amid consolidation risk
Shares of Abbott Laboratories (ABT) are trading near $116 as the week opens, with its rally showing signs of strain after an extended advance. Overbought conditions look ...
  • Ashutosh Sureka
  • 03.08.2026
Abbott shares face cautious technical signals after nearly 2% gain: weekly analysis
Shares of Abbott Laboratories (ABT) are trading near $108 after a nearly 2% rally this week as the chart shows strong momentum but also initial signs of overheating. ...
  • Sholanke Dele
  • 01.08.2026
Abbott Laboratories stock consolidates near $105.70 with technical signals mixed
Abbott Laboratories says Pedialyte has earned its spot on the shelf. The company calls Pedialyte the number one overall trusted oral rehydration solution for fast hydration.Abbott Laboratories ...
  • Ciaran Ryan
  • 29.07.2026
Why is Abbott Laboratories stock up 1.6% today?
Abbott Laboratories (ABT) advanced 1.62% as robust second-quarter results and an upbeat outlook for 2026 earnings fueled renewed buying interest. The move is supported by the price rising above ...
  • Jainam Mehta
  • 29.07.2026
Abbott Laboratories stock gains 2.98 percent amid #WeGiveBlood competition announcement, AbbottNews says
Abbott Laboratories announced that the #WeGiveBlood competition is coming back.The company encouraged people to get ready to donate blood and referenced rolling up sleeves for the event. Details ...
  • Dan Blystone
  • 21.07.2026
What's behind Abbott Laboratories' latest stock pullback?
Abbott Laboratories (ABT) fell 1.65% after opening with a downside gap, as the stock retreated toward intraday support. The move is limited, with Abbott still holding above its 20-day and 50-day ...
  • Oleg Tkachenko
  • 20.07.2026
Abbott Laboratories stock holds near weekly high, eyes resistance after modest climb
Abbott Laboratories stated that the views expressed should not be used for medical diagnosis, treatment, or as a replacement for professional medical advice.Individual symptoms, situations, and ...